Liu et al. revealed that aberrant overexpression of RUNX2 in bladder urothelial carcinoma (BLCA) is indicative of both high infiltration of cancer-associated fibroblasts (CAFs) and poor prognosis in BLCA patients [108]. This evidence concerns the gene RUNX2 and cancer.